Mustang Bio, Inc. financial data

Symbol
MBIO on Nasdaq
Industry
Pharmaceutical Preparations
Location
377 Plantation Street, Worcester, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 28, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 51.2 % -74.1%
Debt-to-equity -254 % -229%
Return On Equity 244 %
Return On Assets -159 % -8.66%

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 14.8M USD -61.8%
Weighted Average Number of Shares Outstanding, Basic 610K shares +254%
Weighted Average Number of Shares Outstanding, Diluted 610K shares +254%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 4.14M USD -57.3%
Operating Income (Loss) -16.2M USD +67%
Nonoperating Income (Expense) 493K USD -48%
Net Income (Loss) Attributable to Parent -15.8M USD +69.5%
Earnings Per Share, Basic -38.6 USD/shares +87.1%
Earnings Per Share, Diluted -38.6 USD/shares +87.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.84M USD +9.71%
Assets, Current 8.61M USD -24.1%
Property, Plant and Equipment, Net 371K USD -88.6%
Operating Lease, Right-of-Use Asset 81K USD -94.8%
Other Assets, Noncurrent 250K USD -70%
Assets 9.31M USD -47.5%
Accounts Payable, Current 7.46M USD +18.1%
Liabilities, Current 12.6M USD -18%
Operating Lease, Liability, Noncurrent 422K USD -78.7%
Liabilities 13.2M USD -25.2%
Retained Earnings (Accumulated Deficit) -397M USD -4.14%
Stockholders' Equity Attributable to Parent -3.87M USD -3249%
Liabilities and Equity 9.31M USD -47.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.32M USD +70.1%
Net Cash Provided by (Used in) Financing Activities 0 USD -100%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 7.32M shares -93%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.84M USD -2.08%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 152M USD +2.99%
Deferred Tax Assets, Gross 152M USD +2.6%
Operating Lease, Liability 878K USD -64.9%
Depreciation 671K USD -63.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 955K USD -68.6%
Property, Plant and Equipment, Gross 7.69M USD 0%
Operating Lease, Liability, Current 456K USD -12.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 439K USD -43.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 516K USD -28.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 77K USD -85.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 269K USD -61.7%
Deferred Tax Assets, Operating Loss Carryforwards 95.1M USD +12.4%
Preferred Stock, Shares Issued 250K shares 0%
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 274K USD +1.86%
Operating Lease, Payments 156K USD +18.2%
Preferred Stock, Shares Outstanding 250K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 30K USD -94.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%